Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Flow from Investing Activities

    Back to Cashflow Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Investing Activities ₹-1,283 Cr₹2.09 Cr₹4,561 Cr₹-528 Cr₹-333 Cr

What is the latest Cash Flow from Investing Activities ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Flow from Investing Activities ratio of GLENMARK PHARMACEUTICALS is ₹-1,283 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Investing Activities
Mar2026₹-1,283 Cr
Mar2025₹2.09 Cr
Mar2024₹4,561 Cr
Mar2023₹-528 Cr
Mar2022₹-333 Cr

How is Cash Flow from Investing Activities of GLENMARK PHARMACEUTICALS Trending?

Years Cash Flow from Investing Activities % Change
Mar2026 ₹-1,283 Cr
Negative
Mar2025 ₹2.09 Cr
-99.95
Mar2024 ₹4,561 Cr
Positive
Mar2023 ₹-528 Cr
Negative
Mar2022 ₹-333 Cr -

Compare Cash Flow from Investing Activities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹62,225.1 Cr -1.8% -7.4% 16.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,684.0 Cr -0.2% -4.9% 5.5% Stock Analytics
DIVIS LABORATORIES ₹242,904.0 Cr 1.3% -2.3% 38.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹172,213.0 Cr -1.5% -5.8% 29.3% Stock Analytics
CIPLA ₹106,138.0 Cr 0.1% -4.2% -14.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,304.0 Cr 1.9% 5.7% 0.4% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.8%

-7.4%

16.6%

SENSEX

0.9%

-0.8%

-10.5%


You may also like the below Video Courses